General
Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent
Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:
- Pfizer says preliminary results of its study show its…
Continue Reading
-
General23 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
Noosa News20 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months
-
Business19 hours agoWhat it means for shareholders
-
Business21 hours agoUp 48% in a month, can Domino’s Pizza shares keep the momentum going?